Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report), Centene (CNC – Research Report) and LifeMD (LFMD – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Roche Holding AG (RHHVF)
In a report released today, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG, with a price target of CHF340.00. The company’s shares closed last Tuesday at $438.21.
According to TipRanks.com, Hector is a 4-star analyst with an average return of
Roche Holding AG has an analyst consensus of Moderate Buy, with a price target consensus of $450.96, implying a 5.6% upside from current levels. In a report issued on March 2, J.P. Morgan also maintained a Hold rating on the stock with a CHF350.00 price target.
See today’s best-performing stocks on TipRanks >>
Centene (CNC)
Barclays analyst Andrew Mok CFA maintained a Buy rating on Centene today and set a price target of $54.00. The company’s shares closed last Tuesday at $36.40.
According to TipRanks.com, CFA is a 1-star analyst with an average return of
Currently, the analyst consensus on Centene is a Hold with an average price target of $44.67, which is a 5.3% upside from current levels. In a report issued on February 25, Truist Financial also reiterated a Buy rating on the stock with a $49.00 price target.
LifeMD (LFMD)
KeyBanc analyst Scott Schoenhaus maintained a Buy rating on LifeMD today. The company’s shares closed last Tuesday at $3.91.
According to TipRanks.com, Schoenhaus has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on LifeMD is a Strong Buy with an average price target of $8.50, a 142.9% upside from current levels. In a report released yesterday, TipRanks – Google also upgraded the stock to Buy with a $3.50 price target.
